Phase I Study of Sorafenib Dosed Continuously With Cyclophosphamide and Doxorubicin
Clinical trial NCT00562913 · COMPLETED
Trial details
- NCT number
- NCT00562913
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2009-06-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.